Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 199 across all filing types
Latest filing 2020-04-10 Regulatory Filings
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
Medacta Launches the MORE in Touch Program
Regulatory Filings Classification · 1% confidence The document is a 'Media Release' dated April 10, 2020, announcing the launch of the 'M.O.R.E. in Touch Program' and the 'Medacta TV Platform' for medical education via webcasts. It details scheduled educational sessions and faculty. This is not a formal regulatory financial filing like a 10-K, IR, or ER. It is a communication aimed at the public/media/investors regarding a new company initiative, specifically related to medical education and support during the pandemic. Since it is a general announcement/communication that doesn't fit the specific categories like AGM-R, 10-K, ER, or DIV, it falls best under the general regulatory/news announcement category, which is RNS (Regulatory Filings) as the fallback for miscellaneous announcements, or potentially a general communication/advertisement, but RNS is the designated fallback for non-specific regulatory news releases.
2020-04-10 English
Publication of 2019 Annual Results
Earnings Release Classification · 1% confidence The document is titled "Publication of 2019 Annual Results" and contains key financial highlights (Sales, Adjusted EBITDA margin) for the full year 2019. It explicitly mentions the "Press Release – Publication of 2019 Annual Results" and discusses the full year performance, which aligns with an Earnings Release (ER) or a summary preceding a full Annual Report (10-K). However, the document is a press release summarizing the annual results and explicitly states that the full "Annual Report 2019 can be downloaded via this link." Furthermore, it announces a webcast to present the Annual Results. According to Rule 2 (The 'MENU VS MEAL' Rule), a document that summarizes results and points to the full report is often classified as an Earnings Release (ER) if it contains the key figures, or a Report Publication Announcement (RPA) if it is purely an announcement of publication. Since this document contains substantial financial data and commentary on the full year performance, it functions as the primary Earnings Release (ER) for the annual period, even though the full 10-K is linked separately. The key focus is the announcement of the annual financial performance highlights. FY 2019
2020-04-06 English
Changes in the Board of Directors of Medacta Group SA
Board/Management Information Classification · 1% confidence The document is explicitly titled "Changes in the Board of Directors of Medacta Group SA" and details that a director, Mr. Marco Gadola, will not stand for re-election at the upcoming annual general meeting. This content directly relates to changes in senior management or the board of directors. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and appears to be an ad-hoc announcement, not a comprehensive report.
2020-03-18 English
Medacta Announces FDA Clearance for Mecta-C Stand Alone Anterior Cervical Interbody Fusion Device
Regulatory Filings Classification · 1% confidence The document is a 'Media Release' dated March 6, 2020, announcing that Medacta received FDA clearance for a specific medical device (Mecta-C Stand Alone). This is a specific operational/product announcement, not a standard financial filing like a 10-K, IR, or ER. It does not fit the definitions for AGM-R, AR, MANG, CT, CAP, DVA, DLST, DIRS, SR, FS, CGR, IRAT, LTR, TAR, MRQ, NAV, DIV, DEF 14A, RPA, SHA, or POS. It is too specific for a general Regulatory Filing (RNS). Since it is an announcement of a significant operational event (FDA clearance), and there is no category for 'Product/Regulatory Approval Announcement', the closest fit among the provided options that covers general corporate news not fitting other specific financial/governance categories is the fallback category, Regulatory Filings (RNS), as this type of announcement is often disseminated via regulatory news services.
2020-03-06 English
Medacta Announces FDA Clearance for Multiple Sports Medicine Products: MectaLock All-Suture Anchors, MectaTap Ti Suture Anchors and MectaFIX CL
Regulatory Filings Classification · 1% confidence The document is a 'Media Release' dated March 4, 2020, announcing that Medacta has received FDA clearance for three new Sports Medicine products. It details the products and their uses but does not contain comprehensive financial statements, management discussion, shareholder voting results, or detailed executive compensation. It is a specific operational announcement regarding product regulatory approval. This type of announcement, which is not a standard periodic financial report (10-K, IR, ER) or a specific corporate action (DIV, CAP, DIRS), fits best under the general 'Regulatory Filings' (RNS) category, as it is a news release about a regulatory event (FDA clearance) that is being disseminated publicly, often required by listing rules, but doesn't match the more specific categories like LTR (Legal Proceedings) or ER (Earnings Release). Given the options, RNS serves as the best fit for a general regulatory/operational news announcement.
2020-03-04 English
Medacta Spotlights Knee Sports Medicine and Knee Arthroplasty at the 2nd M.O.R.E. Australian Knee Symposium
Regulatory Filings Classification · 1% confidence The document is a 'Media Release' from Medacta announcing its participation and spotlighting specific medical topics (Knee Sports Medicine and Knee Arthroplasty) at the 2nd M.O.R.E. Australian Knee Symposium. It details the event schedule, attendees, and the company's commitment to medical education. This type of announcement, which is not a formal financial report (like 10-K, IR, ER) but rather a general corporate update about an event or activity, fits best under the general 'Regulatory Filings' (RNS) category, as it is a broad corporate news release distributed via a service like EQS, and does not match any of the more specific categories like AGM-R, ER, or IP.
2020-02-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.